Meury William
Director at SNDX; EVP & Chief Commercial Officer at Actavis plc; SVP - Marketing at FOREST LABORATORIES INC
- Sold, on record
- $20.5M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Aug 2, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- SNDXSyndax Pharmaceuticals IncDirector
- Actavis plcEVP & Chief Commercial Officer
- FOREST LABORATORIES INCSVP - Marketing
Sales by reason
Form 4 sales per year, every sale on record.
Sales by company
- Actavis plc99,661 shares
- SNDX83,000 shares
- FOREST LABORATORIES INC68,198 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale FOREST LABORATORIES INCUnusualJan 18, 2012 2012
Sold 41,848 shares at $32.06 ($1.3M)
Meury William, SVP - Marketing
Sold 32.4% of holdings ($4.1M position)87,406 shares leftFirst sale on recordFiling
- 2 Form 4 sale FOREST LABORATORIES INCPlan not statedFeb 6, 2013 +385 days
Sold 26,350 shares at $35.73 ($942k)
Meury William, SVP - Marketing
Sold 24.3% of holdings ($3.9M position)81,916 shares leftFiling
- 3 Form 4 sale Actavis plcPlan not statedNov 26, 2014 +658 days
Sold 4,550 shares at $269.14 ($1.2M)
Meury William, Officer
Sold 5.3% of holdings ($23.3M position)81,939 shares leftFirst sale on recordFiling
- 4 Form 4 sale Actavis plcPlan not statedDec 1, 2017 +1101 days
Sold 11,807 shares at $173.89 ($2.1M)
Meury William, Chief Commercial Officer
Sold 17.2% of holdings ($12M position)57,021 shares leftFirst sale on recordFiling
- 5 Form 4 sale Actavis plcUnusualFeb 14, 2018 +75 days
Sold 58,879 shares at $160.62 ($9.5M)
Meury William, Chief Commercial Officer
Sold 74.9% of holdings ($12.6M position)19,721 shares leftFiling
- 6 Form 4 sale Actavis plcUnusualMay 17, 2018 +92 days
Sold 24,425 shares at $154.59 ($3.8M)
Meury William, EVP & Chief Commercial Officer
Sold 60.8% of holdings ($6.2M position)15,729 shares leftFiling
- 7 Form 144 notice SNDXNoticeAug 2, 2023 +1903 days
Filed to sell 83,000 shares ($1.7M)
Meury William, Director
10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale SNDXRoutineAug 2, 2023 same day
Sold 83,000 shares at $20.46 ($1.7M)
Meury William, Director
10b5-1 planSold 63.4% of holdings ($2.7M position)48,000 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2023 | Aug 3, 2023 | SNDX | Director | Form 4 sale | 83,000 | $1.7M | 63.4% | Routine | SEC |
| Aug 2, 2023 | Aug 2, 2023 | SNDX | Director | Form 144 notice | 83,000 | $1.7M | Notice | SEC | |
| May 17, 2018 | May 21, 2018 | Actavis plc | EVP & Chief Commercial Officer | Form 4 sale | 24,425 | $3.8M | 60.8% | Unusual | SEC |
| Feb 14, 2018 | Feb 16, 2018 | Actavis plc | Chief Commercial Officer | Form 4 sale | 58,879 | $9.5M | 74.9% | Unusual | SEC |
| Dec 1, 2017 | Dec 4, 2017 | Actavis plc | Chief Commercial Officer | Form 4 sale | 11,807 | $2.1M | 17.2% | Plan not stated | SEC |
| Nov 26, 2014 | Dec 1, 2014 | Actavis plc | Officer | Form 4 sale | 4,550 | $1.2M | 5.3% | Plan not stated | SEC |
| Feb 6, 2013 | Feb 8, 2013 | FOREST LABORATORIES INC | SVP - Marketing | Form 4 sale | 26,350 | $942k | 24.3% | Plan not stated | SEC |
| Jan 18, 2012 | Jan 19, 2012 | FOREST LABORATORIES INC | SVP - Marketing | Form 4 sale | 41,848 | $1.3M | 32.4% | Unusual | SEC |